Table 6. Summary of effect of performance status, haemoglobin and renal function on PFS.
| Patient number | Median progression-free survival (months) | Interquartile range (months) | Significance (p values) | ||
|---|---|---|---|---|---|
| Performance status | 0 | 10 | 7.4 | 3.5–17.1 | No significance seen |
| 1 | 39 | 9.1 | 3.7–14.3 | ||
| 2 | 11 | 2.2 | 1.2–2.9 | ||
| 3 | 1 | 0.2 | |||
| Estimated GFR ≥34 mls/min/1.73 m2 | Yes | 70 | 8.8 | 3.7–15.9 | 0.004 |
| No | 17 | 3.1 | 2.2–8.3 | ||
| Haemoglobin ≥100 g/L | Yes | 72 | 8.5 | 3.0–15.7 | 0.004 |
| No | 15 | 3.2 | 2.6–9.1 | ||